Efficient Stable Cell Line Generation of Survivin as an In Vitro Model for Specific Functional Analysis in Apoptosis

Rashid Houshdarpour1, Farangis Ataei2, Saman Hosseinkhani1

  • 1Department of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.

Insights

Overexpressing survivin, an anti-apoptotic protein, in HEK cells enhances resistance to cancer treatments and reduces apoptosis. This finding is crucial for developing novel cancer therapies and drug screening methods.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Identifying proteins affecting cancer treatment efficiency is vital.
  • Survivin, an anti-apoptotic protein, regulates cell death and survival.
  • Stable overexpression of genes in recombinant cells aids treatment studies and drug screening.

Purpose of the Study:

  • To investigate the link between survivin levels and apoptosis rate.
  • To develop an in vitro model for studying survivin's role in apoptosis resistance.
  • To analyze the effects of survivin overexpression on cellular responses to stimuli.

Main Methods:

  • Development of survivin-reconstituted HEK (HEK-S) cells.
  • Reverse Transcription Polymerase Chain Reaction (RT-PCR) and Western blot for survivin expression analysis.
  • Morphological observation, survival assays, caspase activity assays, ROS level, ATP content measurement, and scratching analysis.

Main Results:

  • Survivin was constitutively overexpressed in HEK-S cells.
  • HEK-S cells exhibited significant resistance to apoptotic stimuli, decreased caspase 3/7 activity, increased ATP content, and reduced ROS levels.
  • Survivin overexpression conferred resistance to laser irradiation and drug treatment in neighboring cells, while YM155 (a survivin inhibitor) enhanced apoptosis and reduced invasion.

Conclusions:

  • Survivin overexpression confers significant resistance to apoptosis and various cellular stresses.
  • Survivin plays a critical role in regulating cell survival and resistance to cancer treatments.
  • Targeting survivin may offer a therapeutic strategy for overcoming treatment resistance in cancer.